How to Conduct Post-Market Surveillance for Overseas Registration of Home-Use Medical Devices

Answer: After obtaining overseas registration, manufacturers of home-use medical devices must establish a structured post-market surveillance program to maintain regulatory compliance. The program should cover four key dimensions: (1) regulatory requirements—reconfirm risk classification and registration pathway in the target country; (2) internal processes—maintain a certificate management ledger, implement change control, and set up adverse event reporting; (3) evidence retention—continuously update risk management, performance, clinical, labeling, and adverse event data, distinguishing reusable versus localized documents; and (4) agent collaboration—ensure the local authorized representative is valid, informed, and operationally capable. Without such a program, registration certificates may be suspended, revoked, or fail renewal.

Key Summary

After completing overseas registration and obtaining registration certificates, home-use medical device companies must maintain compliance through post-market surveillance. This determines whether the product can continue to be sold legally. Companies should address four levels: regulatory requirements, internal processes, evidence retention, and agent collaboration. First, reconfirm the product's risk classification and registration pathway in the target country; do not rely solely on the initial registration assessment. Second, establish a registration certificate management ledger to track validity periods, agent information, and change status. For documentation, continuously generate the latest risk management reports, performance data, clinical evidence, labeling/instructions, and adverse event statistics, and distinguish what can be reused versus what must be localized. Common risks include ignoring certificate validity, failing to apply for supplementary approval for design changes, not notifying regulators of agent changes, and lacking adverse event reporting procedures. Companies should develop post-market surveillance procedure documents, establish adverse event reporting processes, regularly review regulatory changes, and plan for renewal in advance. For multi-country registrations, it is recommended to build a unified technical file master and standardized data collection processes to reduce repetitive work and correction risks. Local agents and certificate control must be included in core corporate management, with regular verification of their service capabilities.

Source: Compiled from AIMEILI registration practice database, medical device international registration knowledge base, and public regulatory information. Specific projects should be based on the target country's latest regulatory requirements and product documentation.

Applicable Scenarios and Core Questions

Home-use medical device companies that complete overseas registration and obtain certificates often assume they can sell stably for the long term. In reality, post-market surveillance determines whether the product can continue to comply. In this article, "home-use medical devices" include blood pressure monitors, blood glucose meters, thermometers, pulse oximeters, oxygen concentrators, ventilators, physiotherapy devices, and other similar products. Target markets include GHWP member countries, Southeast Asia, the Middle East, Latin America, and other regions.

Post-market surveillance after overseas registration involves tracking regulatory changes, maintaining certificates, controlling product changes, reporting adverse events, updating labels and instructions, and coordinating with agent organizations. The core question companies must answer is: How to maintain registration validity and fulfill ongoing obligations during the validity period in the target country?

Many companies invest heavily in the initial registration stage but neglect post-market obligations, leading to suspension, revocation, or renewal failure of registration certificates. Therefore, companies must establish a management mechanism covering post-registration activities and integrate post-market obligations into the quality management system and resource planning.

To address this issue, companies should start from four levels: regulatory requirements, internal processes, evidence retention, and agent collaboration.

Registration Determination Logic

The first step of post-market surveillance is to reconfirm the risk classification and registration pathway of the product. Different countries have vastly different regulatory models for home-use medical devices. For example, in most GHWP member countries, home blood pressure monitors and thermometers are typically Class II, but individual countries may classify them as Class I or Class III. Classification directly affects post-registration obligations.

Companies need to re-examine the regulatory framework of the target country rather than simply using the initial registration assessment. They should check the latest regulations or guidance documents to confirm whether the product has been reclassified and whether special standards exist.

The registration determination logic should also include a review of existing registration pathways. If a company simultaneously maintains NMPA registration, CE marking, FDA 510(k), or MDSAP certificates, it should identify which existing technical files can serve as the basis for post-market surveillance and which need to be localized according to target country requirements.

For multi-country registrations, it is recommended that companies first establish a list containing key elements such as registration certificate number, validity period, approving authority, classification, agent information, and change status. This list is the underlying data for post-market surveillance, and all subsequent activities revolve around it.

During operation, it is also necessary to determine whether the target country requires annual updates, periodic re-registration, or on-site audits. Some countries require manufacturers to submit renewal materials before the certificate expires, while others may require system audits or remote assessments.

Documentation and Evidence

Post-market surveillance is not simply about keeping old files; it requires continuously generating and managing new evidence.

The core documents required by companies include: latest risk management reports, performance verification and stability data, clinical evaluation or clinical evidence, labeled versions of labels and instructions, quality system records (ISO 13485 or MDSAP certificates), and post-market adverse event reports and trend analysis.

For home-use medical devices, the risk of injury due to user error deserves attention. Companies are advised to collect user feedback, customer service records, return data, and other information to form real-world evidence.

Different countries have different evidence requirements. For example, under the U.S. FDA, the substantial equivalence determination for 510(k) needs to be updated; under the EU MDR, post-market surveillance plans and Periodic Safety Update Reports (PSUR) must be submitted; in GHWP member countries, registration change applications are typically required.

Companies should establish a document management procedure to ensure that every version of a document can be traced back to its approved status. They should also preserve correspondence with agents, as many countries require local agents to communicate with regulatory authorities.

Special note: Some countries require that the registration certificate holder have a fixed corporate address or legal representative in the local area. Therefore, the authorization documents and authenticity documents of professional local agents or authorized representatives must remain valid.

Common Mistakes

• Mistakenly believing that registration certificates are permanently valid and ignoring expiry dates and renewal times, causing products to be withdrawn from the market after certificates expire.
• Focusing only on initial registration technical files and not considering whether post-market modifications require re-application, such as replacing core components, modifying instructions, or changing intended use. Such changes often require supplementary applications.
• Ignoring the role of local agents, allowing agents to be nominal without providing necessary information, or failing to notify regulators after an agent change, causing communication barriers.
• Failing to establish adverse event reporting procedures or not knowing which regulatory authority to report to and within what timeframe, creating compliance risks.
• Translating materials approved in other countries directly and submitting them without considering the target country's clinical data requirements and local use environment differences.
• Keeping post-market surveillance only at the document level, lacking coordination with production, sales, and after-sales departments, so real post-market performance data cannot be obtained.
• Not paying attention to regulatory changes in the target country, such as release of new standards, import policy adjustments, fee changes, etc., leading to abnormal registration certificate status.

Manufacturer Preparation Checklist

• Establish a registration certificate management ledger recording product name, certificate number, validity period, classification, agent information, and approved scope.
• Develop post-market surveillance procedure documents that clarify departmental responsibilities, information collection channels, and decision-making mechanisms.
• Confirm the contact information and validity of authorization documents of the local agent or authorized representative, and regularly renew or update them.
• Collect and retain the latest versions of labels, instructions, and technical documents, and verify consistency with the approved versions.
• Establish an adverse event reporting process, identifying reporting timelines, responsible persons, and the list of regulatory authorities.
• Develop change management rules, clarifying which changes require filing, notification, or formal application with target country regulators.
• Review the latest regulations and guidelines of the target country, especially specific standards and safety requirements affecting home-use devices.
• Regularly review the status of registration certificates and plan renewal timelines reasonably to avoid urgent submissions at the last minute.

AIMEILI Regulatory Interpretation

The most common misjudgment by companies is underestimating the legal responsibility of post-registration maintenance. Successful registration is only the starting point; every subsequent regulation can change the rules of the game. AIMEILI recommends establishing a post-market surveillance budget and responsible personnel at the project initiation stage, rather than waiting until the certificate is about to expire to take remedial action.

In the early stage of a project, a compliance gap analysis should be conducted to clarify the specific post-market requirements for home-use devices in the target country, including whether annual maintenance fees are required, whether PSURs must be submitted, and whether on-site audits are required.

Reusable materials include basic technical files, performance test reports, and ISO 13485 system evidence. However, labels, instructions, clinical evaluations, and adverse event report formats must be prepared according to local requirements; any "direct translation" is not acceptable.

Local agents, certificate control, changes, and renewals must be included in the core management of the company. An agent is not merely a contact person, but an extension of legal responsibility. Companies should regularly audit the service capabilities of agents to ensure that certificates remain under control.

For companies with multi-country registrations, AIMEILI recommends building a unified technical file master and marking differences according to different country requirements. Standardize post-market data collection to reduce duplicate work and correction risks, and improve renewal efficiency.

Frequently Asked Questions

Do home-use medical devices need to establish a post-market surveillance plan?

Yes. Almost all major medical device regulatory systems require manufacturers to fulfill post-market surveillance obligations. Even low-risk Class I devices require monitoring of abnormal events and updating safety information. Home-use devices have a special use environment and high user error rates, so they require systematic collection of real-world data.

How long is the registration certificate valid generally? How to renew it after expiration?

Validity periods vary widely by country, typically ranging from 3 to 5 years, or sometimes long-term valid. Renewal usually requires submission of the existing registration certificate, recent quality management system evidence, and a declaration that no significant changes have occurred. Some countries also require the participation of a local agent. Companies should start the renewal process at least 6-12 months before the expiration date.

If a product undergoes minor design changes, does the manufacturer need to notify the regulatory authority?

It depends. Minor changes that do not affect safety and effectiveness, such as internal component changes, may only require updating technical files without applying for a new permit. However, changes involving intended use, key performance parameters, materials, or labeling must be notified through a change application as required. Companies should assess each change item-by-item based on target country regulations and competent authority guidelines.

How should a company handle user complaints or adverse events?

Companies should investigate and assess the severity and causal relationship of the event. For events that meet reporting criteria, they must report to the regulatory authority within the required timeframe (usually 30 days or 15 days) and simultaneously notify the local agent. For serious or mass events, risk corrective actions and recalls may also be necessary.

Continue Reading

• How to Submit Multiple Models in Groups for Overseas Registration of Home-Use Medical Devices
• How to Prepare Registration Dossiers for Overseas Registration of Software Medical Devices
• How to Organize Technical Documentation for Overseas Registration of Software Medical Devices
• What Are Common Reasons for Supplementary Information Requests in Overseas Registration of Software Medical Devices?
• How to Prepare Performance Verification Materials for Overseas Registration of Software Medical Devices
• How to Prepare Registration Dossiers for AI Medical Devices

Content Review and Applicability Boundary

Content Author: AIMEILI Regulatory Editorial Department

Professional Review: AIMEILI Medical Device International Registration Project Team

Source Principles: Priority is given to official regulatory authorities, international organizations, standard-setting bodies, and public regulatory materials; industry media and project experience are used only as auxiliary reference.

Applicability Boundary: This article is intended for preliminary understanding, document preparation, and project planning. It does not replace formal requirements from target country regulators, testing conclusions, or legal opinions.